Table 2.

Comparison of short-term outcomes: D1 lymphadenectomy vs. D2 lymphadenectomy in gastric cancer treatment [51,59,60,61,62].

Short-Term Outcomes	D1 Lymphadenectomy	D2 Lymphadenectomy
Length of Hospital Stay (days)	8–14	12–16
Postoperative Morbidity (%)	20–30	25–35
Mortality Rate (%)	1–5	2–7

(Table 2 provides a general overview of the short-term outcomes, but it is important to note that these ranges may vary depending on several factors, such as the patient’s overall health, tumor stage, and surgical skill. Additionally, these short-term outcomes provide a general overview and should be considered in conjunction with long-term outcomes and other factors when making treatment decisions for gastric cancer patients) [51,59,60,61,62].